128 related articles for article (PubMed ID: 37625895)
1. Predicting 10-year breast cancer mortality risk in the general female population in England: a model development and validation study.
Clift AK; Collins GS; Lord S; Petrou S; Dodwell D; Brady M; Hippisley-Cox J
Lancet Digit Health; 2023 Sep; 5(9):e571-e581. PubMed ID: 37625895
[TBL] [Abstract][Full Text] [Related]
2. Development and internal-external validation of statistical and machine learning models for breast cancer prognostication: cohort study.
Clift AK; Dodwell D; Lord S; Petrou S; Brady M; Collins GS; Hippisley-Cox J
BMJ; 2023 May; 381():e073800. PubMed ID: 37164379
[TBL] [Abstract][Full Text] [Related]
3. Predicting the future risk of lung cancer: development, and internal and external validation of the CanPredict (lung) model in 19·67 million people and evaluation of model performance against seven other risk prediction models.
Liao W; Coupland CAC; Burchardt J; Baldwin DR; ; Gleeson FV; Hippisley-Cox J
Lancet Respir Med; 2023 Aug; 11(8):685-697. PubMed ID: 37030308
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of clinical prediction models for breast cancer incidence and mortality: a protocol for a dual cohort study.
Clift AK; Hippisley-Cox J; Dodwell D; Lord S; Brady M; Petrou S; Collins GS
BMJ Open; 2022 Mar; 12(3):e050828. PubMed ID: 35351695
[TBL] [Abstract][Full Text] [Related]
5. Multi-cancer risk stratification based on national health data: a retrospective modelling and validation study.
Jung AW; Holm PC; Gaurav K; Hjaltelin JX; Placido D; Mortensen LH; Birney E; Brunak SR; Gerstung M
Lancet Digit Health; 2024 Jun; 6(6):e396-e406. PubMed ID: 38789140
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of risk prediction equations to estimate survival in patients with colorectal cancer: cohort study.
Hippisley-Cox J; Coupland C
BMJ; 2017 Jun; 357():j2497. PubMed ID: 28620089
[No Abstract] [Full Text] [Related]
7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
8. Validation and development of models using clinical, biochemical and ultrasound markers for predicting pre-eclampsia: an individual participant data meta-analysis.
Allotey J; Snell KI; Smuk M; Hooper R; Chan CL; Ahmed A; Chappell LC; von Dadelszen P; Dodds J; Green M; Kenny L; Khalil A; Khan KS; Mol BW; Myers J; Poston L; Thilaganathan B; Staff AC; Smith GC; Ganzevoort W; Laivuori H; Odibo AO; Ramírez JA; Kingdom J; Daskalakis G; Farrar D; Baschat AA; Seed PT; Prefumo F; da Silva Costa F; Groen H; Audibert F; Masse J; Skråstad RB; Salvesen KÅ; Haavaldsen C; Nagata C; Rumbold AR; Heinonen S; Askie LM; Smits LJ; Vinter CA; Magnus PM; Eero K; Villa PM; Jenum AK; Andersen LB; Norman JE; Ohkuchi A; Eskild A; Bhattacharya S; McAuliffe FM; Galindo A; Herraiz I; Carbillon L; Klipstein-Grobusch K; Yeo S; Teede HJ; Browne JL; Moons KG; Riley RD; Thangaratinam S
Health Technol Assess; 2020 Dec; 24(72):1-252. PubMed ID: 33336645
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of QMortality risk prediction algorithm to estimate short term risk of death and assess frailty: cohort study.
Hippisley-Cox J; Coupland C
BMJ; 2017 Sep; 358():j4208. PubMed ID: 28931509
[No Abstract] [Full Text] [Related]
10. Living risk prediction algorithm (QCOVID) for risk of hospital admission and mortality from coronavirus 19 in adults: national derivation and validation cohort study.
Clift AK; Coupland CAC; Keogh RH; Diaz-Ordaz K; Williamson E; Harrison EM; Hayward A; Hemingway H; Horby P; Mehta N; Benger J; Khunti K; Spiegelhalter D; Sheikh A; Valabhji J; Lyons RA; Robson J; Semple MG; Kee F; Johnson P; Jebb S; Williams T; Hippisley-Cox J
BMJ; 2020 Oct; 371():m3731. PubMed ID: 33082154
[TBL] [Abstract][Full Text] [Related]
11. Effect of competing mortality risks on predictive performance of the QRISK3 cardiovascular risk prediction tool in older people and those with comorbidity: external validation population cohort study.
Livingstone S; Morales DR; Donnan PT; Payne K; Thompson AJ; Youn JH; Guthrie B
Lancet Healthy Longev; 2021 Jun; 2(6):e352-e361. PubMed ID: 34100008
[TBL] [Abstract][Full Text] [Related]
12. Predicting the risk of pancreatic cancer in adults with new-onset diabetes: development and internal-external validation of a clinical risk prediction model.
Clift AK; Tan PS; Patone M; Liao W; Coupland C; Bashford-Rogers R; Sivakumar S; Hippisley-Cox J
Br J Cancer; 2024 Jun; 130(12):1969-1978. PubMed ID: 38702436
[TBL] [Abstract][Full Text] [Related]
13. An external validation of the QCovid risk prediction algorithm for risk of mortality from COVID-19 in adults: a national validation cohort study in England.
Nafilyan V; Humberstone B; Mehta N; Diamond I; Coupland C; Lorenzi L; Pawelek P; Schofield R; Morgan J; Brown P; Lyons R; Sheikh A; Hippisley-Cox J
Lancet Digit Health; 2021 Jul; 3(7):e425-e433. PubMed ID: 34049834
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of QDiabetes-2018 risk prediction algorithm to estimate future risk of type 2 diabetes: cohort study.
Hippisley-Cox J; Coupland C
BMJ; 2017 Nov; 359():j5019. PubMed ID: 29158232
[No Abstract] [Full Text] [Related]
15. The implications of competing risks and direct treatment disutility in cardiovascular disease and osteoporotic fracture: risk prediction and cost effectiveness analysis.
Guthrie B; Rogers G; Livingstone S; Morales DR; Donnan P; Davis S; Youn JH; Hainsworth R; Thompson A; Payne K
Health Soc Care Deliv Res; 2024 Feb; 12(4):1-275. PubMed ID: 38420962
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.
Williams C; Brunskill S; Altman D; Briggs A; Campbell H; Clarke M; Glanville J; Gray A; Harris A; Johnston K; Lodge M
Health Technol Assess; 2006 Sep; 10(34):iii-iv, ix-xi, 1-204. PubMed ID: 16959170
[TBL] [Abstract][Full Text] [Related]
17. Development and validation of risk prediction algorithms to estimate future risk of common cancers in men and women: prospective cohort study.
Hippisley-Cox J; Coupland C
BMJ Open; 2015 Mar; 5(3):e007825. PubMed ID: 25783428
[TBL] [Abstract][Full Text] [Related]
18. A prognostic model, including quantitative fetal fibronectin, to predict preterm labour: the QUIDS meta-analysis and prospective cohort study.
Stock SJ; Horne M; Bruijn M; White H; Heggie R; Wotherspoon L; Boyd K; Aucott L; Morris RK; Dorling J; Jackson L; Chandiramani M; David A; Khalil A; Shennan A; Baaren GV; Hodgetts-Morton V; Lavender T; Schuit E; Harper-Clarke S; Mol B; Riley RD; Norman J; Norrie J
Health Technol Assess; 2021 Sep; 25(52):1-168. PubMed ID: 34498576
[TBL] [Abstract][Full Text] [Related]
19. Development and evaluation of a risk assessment tool for the personalized screening of breast cancer in Chinese populations: A prospective cohort study.
Zhu J; Wang L; Gong W; Li X; Wang Y; Zhu C; Li H; Shi L; Yang C; Du L
Cancer; 2024 Apr; 130(S8):1403-1414. PubMed ID: 37916832
[TBL] [Abstract][Full Text] [Related]
20. The clinical effectiveness and cost-effectiveness of different surveillance mammography regimens after the treatment for primary breast cancer: systematic reviews registry database analyses and economic evaluation.
Robertson C; Arcot Ragupathy SK; Boachie C; Dixon JM; Fraser C; Hernández R; Heys S; Jack W; Kerr GR; Lawrence G; MacLennan G; Maxwell A; McGregor J; Mowatt G; Pinder S; Ternent L; Thomas RE; Vale L; Wilson R; Zhu S; Gilbert FJ
Health Technol Assess; 2011 Sep; 15(34):v-vi, 1-322. PubMed ID: 21951942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
